Company / CapEx per Share
SELLAS Life Sciences Group, Inc. CapEx per Share History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2016
5-year range
-
FY2015-FY2016
Trend
-47.0%
vs FY2015
Sector context
#175 of 192
Health Care
What the data says
Among 192 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 9% for capex per share.
Based on SEC 10-K filings.
0.00 in FY2016.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 192This company $0.00 Sector average $3.54
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2016, capex per share decreased 47.0% year-over-year.
- Ranks #175 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.00 | -47.0% |
| FY2015 | $0.00 | +168.4% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026